Decisional Outcomes of Maternal Disclosure of <i>BRCA1</i>/<i>2</i> Genetic Test Results to Children
Kenneth P. Tercyak(Georgetown University), Andrea Farkas Patenaude(Harvard University), Katherine A. Schneider(Dana-Farber Cancer Institute), Beth N. Peshkin(Georgetown University), Darren Mays(Georgetown University), Heiðdís Valdimarsdóttir(Reykjavík University), Tiffani A. DeMarco(Georgetown University), Judy E. Garber(Dana-Farber Cancer Institute)
Cited by 32
Related Papers
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
|The Lancet|2010|1.6k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k